167 related articles for article (PubMed ID: 22669472)
1. Prognostic value of quality of life measured after treatment on subsequent survival in patients with nasopharyngeal carcinoma.
Tsai WL; Chien CY; Huang HY; Liao KC; Fang FM
Qual Life Res; 2013 May; 22(4):715-23. PubMed ID: 22669472
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment quality of life as a predictor of distant metastasis and survival for patients with nasopharyngeal carcinoma.
Fang FM; Tsai WL; Chien CY; Chen HC; Hsu HC; Huang TL; Lee TF; Huang HY; Lee CH
J Clin Oncol; 2010 Oct; 28(28):4384-9. PubMed ID: 20713853
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRT.
Guo SS; Hu W; Chen QY; Li JM; Zhu SH; He Y; Li JW; Xia L; Ji L; Lin CY; Liu LT; Tang LQ; Guo L; Mo HY; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Hong MH; Shao JY; Sun Y; Ma J; Fan YY; Mai HQ
BMC Cancer; 2018 Jan; 18(1):114. PubMed ID: 29386004
[TBL] [Abstract][Full Text] [Related]
4. Improvement in quality of life in patients with nasopharyngeal carcinoma treated with non-invasive extracorporeal radiofrequency in combination with chemoradiotherapy.
Zhao C; Chen J; Yu B; Chen X
Int J Radiat Biol; 2014 Oct; 90(10):853-8. PubMed ID: 24758521
[TBL] [Abstract][Full Text] [Related]
5. Quality of life and survival outcome for patients with nasopharyngeal carcinoma treated by volumetric-modulated arc therapy versus intensity-modulated radiotherapy.
Huang TL; Tsai MH; Chuang HC; Chien CY; Lin YT; Tsai WL; Fang FM
Radiat Oncol; 2020 Apr; 15(1):84. PubMed ID: 32307024
[TBL] [Abstract][Full Text] [Related]
6. Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study.
Fang FM; Chien CY; Tsai WL; Chen HC; Hsu HC; Lui CC; Huang TL; Huang HY
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):356-64. PubMed ID: 18355980
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of xerostomia-related quality of life for nasopharyngeal carcinoma treated by IMRT: based on the EORTC QLQ-C30 and H&N35 questionnaires.
Bian X; Song T; Wu S
Expert Rev Anticancer Ther; 2015 Jan; 15(1):109-19. PubMed ID: 25231774
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment quality of life as a prognostic factor for early survival and functional outcomes in patients with head and neck cancer.
Yang CJ; Roh JL; Kim MJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Qual Life Res; 2016 Jan; 25(1):165-74. PubMed ID: 26156405
[TBL] [Abstract][Full Text] [Related]
9. Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy.
Huang TL; Chien CY; Tsai WL; Liao KC; Chou SY; Lin HC; Dean Luo S; Lee TF; Lee CH; Fang FM
Head Neck; 2016 Apr; 38 Suppl 1():E1026-32. PubMed ID: 26041548
[TBL] [Abstract][Full Text] [Related]
10. Concurrent chemoradiotherapy degrades the quality of life of patients with stage II nasopharyngeal carcinoma as compared to radiotherapy.
Pan XB; Huang ST; Chen KH; Jiang YM; Ma JL; Qu S; Li L; Chen L; Zhu XD
Oncotarget; 2017 Feb; 8(8):14029-14038. PubMed ID: 28152511
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of pretreatment and recovery duration of cranial nerve palsy in nasopharyngeal carcinoma.
Mo HY; Sun R; Sun J; Zhang Q; Huang WJ; Li YX; Yang J; Mai HQ
Radiat Oncol; 2012 Sep; 7():149. PubMed ID: 22958729
[TBL] [Abstract][Full Text] [Related]
12. Concurrent chemoradiotherapy by simultaneously integrated boost volumetric-modulated arc therapy for nasopharyngeal carcinoma-toxicity/quality of life and survival.
Fang FM; Huang TL; Lin YH; Chien CY; Chuang HC; Luo SD; Lin HC; Lin YT; Li SH; Liao KC; Tsai WL
Head Neck; 2019 May; 41(5):1282-1289. PubMed ID: 30548091
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiotherapy provides better quality of life than two-dimensional conventional radiotherapy for patients with stage II nasopharyngeal carcinoma.
Pan XB; Huang ST; Chen KH; Jiang YM; Ma JL; Qu S; Li L; Chen L; Zhu XD
Oncotarget; 2017 Jul; 8(28):46211-46218. PubMed ID: 28515352
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy.
Lin YH; Huang TL; Chien CY; Chen HC; Hsu HC; Huang EY; Wang CJ; Huang YJ; Wang YM; Huang CC; Chou SY; Liao KC; Fang FM
Radiat Oncol; 2018 Mar; 13(1):45. PubMed ID: 29554940
[TBL] [Abstract][Full Text] [Related]
15. Baseline functioning scales of EORTC QLQ-C30 predict overall survival in patients with gastrointestinal cancer: a meta-analysis.
Zang Y; Qiu Y; Sun Y; Fan Y
Qual Life Res; 2024 Jun; 33(6):1455-1468. PubMed ID: 38227073
[TBL] [Abstract][Full Text] [Related]
16. Combined prognostic value of pretreatment anemia and cervical node necrosis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: A large-scale retrospective study.
Zhang LL; Zhou GQ; Li YY; Tang LL; Mao YP; Lin AH; Ma J; Qi ZY; Sun Y
Cancer Med; 2017 Dec; 6(12):2822-2831. PubMed ID: 29034992
[TBL] [Abstract][Full Text] [Related]
17. Physical distress, emotional status, and quality of life in patients with nasopharyngeal cancer complicated by post-radiotherapy endocrinopathy.
Lue BH; Huang TS; Chen HJ
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):28-34. PubMed ID: 17765405
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of phosphorylated Raf kinase inhibitory protein at serine 153 and its predictive effect on the clinical response to radiotherapy in nasopharyngeal carcinoma.
Li S; Liu T; Mo W; Hou Q; Zhou Y; Liu M; He Z; Liu Z; Chen Q; Wang H; Guo X; Xia W; Zeng M; Zhao H
Radiat Oncol; 2016 Sep; 11(1):121. PubMed ID: 27647315
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients.
Liu LT; Chen QY; Tang LQ; Guo SS; Guo L; Mo HY; Chen MY; Zhao C; Guo X; Qian CN; Zeng MS; Bei JX; Tan J; Chen S; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
Cancer Res Treat; 2018 Jan; 50(1):19-29. PubMed ID: 28392551
[TBL] [Abstract][Full Text] [Related]
20. Post-treatment serum lactic dehydrogenase as a predictive indicator for distant metastasis and survival of patients with nasopharyngeal carcinoma.
Wang J; Li L; Dong BQ; Xu YJ; Zheng YD; Sun ZW; Yang Y; Chen YY; Chen XZ; Chen M
Oncotarget; 2016 May; 7(19):27458-67. PubMed ID: 27050275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]